Here’s what you should know:
1. With an estimated 41,000 new liver cancer cases and around 29,000 liver cancer-related deaths in 2017, U.S.-based liver cancer rates have been rising steadily since the mid 1970s.
2. Researchers expect liver cancer rates to continue rising through 2030.
3. Researchers attribute high hepatitis C infection rates in baby boomers, rising general obesity and high type II diabetes rates to the increase in liver cancer.
4. Although liver cancer survival rates have risen over several decades, only one in five patients survived five years after a diagnosis.
5. There’s a high level of disparity in liver cancer patients by race/ethnicity and by geographical location.
Rates are lowest in North Dakota (3.8 per 100,000) and highest in Washington, D.C. (9.6 per 100,000).
More articles on gastroenterology:
FDA grants molecular test for intestinal bacteria 510(k) clearance — 3 insights
Some stage III colorectal cancer may only need three months of chemotherapy — 5 study insights
GI leader to know: Dr. John Weippert of NEO Gastroenterology and Endoscopy Center
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
